RootPath Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 9

RootPath General Information

Description

Developer of an immune and cell therapy designed to bridge precision medicine and cancer immunotherapy. The company's cell therapy focuses on the analysis and manipulation of single immune cells to functionally decipher anti-tumor immunity, enabling drug developers, physicians, and patients to precisely monitor, modulate, and steer the immune system for a revolution in the diagnosis and treatment of cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 111 Speen Street
  • 2nd Floor
  • Framingham, MA 01701
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 111 Speen Street
  • 2nd Floor
  • Framingham, MA 01701
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RootPath Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator Completed Product Development
4. Early Stage VC (Series B) 25-Aug-2021 Completed Product Development
3. Early Stage VC (Series A) 06-Jan-2020 Completed Product Development
2. Seed Round 30-Aug-2018 $7M $7M Completed Product Development
1. Accelerator/Incubator 12-Oct-2017 Completed Startup
To view RootPath’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

RootPath Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an immune and cell therapy designed to bridge precision medicine and cancer immunotherapy. The company's ce
Drug Discovery
Framingham, MA
13 As of 2023

Plymouth Meeting, PA
 

Pittsburgh, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

RootPath Competitors (24)

One of RootPath’s 24 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Noveome Biotherapeutics Venture Capital-Backed Pittsburgh, PA
Verseau Therapeutics Venture Capital-Backed Auburndale, MA
Carisma Therapeutics Formerly VC-backed Philadelphia, PA
Allogene Therapeutics Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 24 competitors. Get the full list »

RootPath Patents

RootPath Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023174398-A1 Synthetic tumor-infiltrating lymphocytes (tils) Inactive 17-Mar-2022
WO-2023096890-A1 Compositions and methods for polynucleotide assembly Inactive 24-Nov-2021
AU-2021366741-A1 Compositions and methods for t-cell receptor identification Inactive 23-Oct-2020
AU-2021366741-A9 Compositions and methods for t-cell receptor identification Inactive 23-Oct-2020
CA-3194664-A1 Compositions and methods for t-cell receptor identification Pending 23-Oct-2020 G01N33/5759
To view RootPath’s complete patent history, request access »

RootPath Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RootPath Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
CDH Investments PE/Buyout Minority
Hony Capital PE/Buyout Minority
Sky9 Capital Venture Capital Minority
MPC (Beijing) Venture Capital Minority
Baidu Ventures Corporate Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

RootPath FAQs

  • When was RootPath founded?

    RootPath was founded in 2017.

  • Where is RootPath headquartered?

    RootPath is headquartered in Framingham, MA.

  • What is the size of RootPath?

    RootPath has 13 total employees.

  • What industry is RootPath in?

    RootPath’s primary industry is Drug Discovery.

  • Is RootPath a private or public company?

    RootPath is a Private company.

  • What is RootPath’s current revenue?

    The current revenue for RootPath is .

  • How much funding has RootPath raised over time?

    RootPath has raised $68M.

  • Who are RootPath’s investors?

    CDH Investments, Hony Capital, Sky9 Capital, MPC (Beijing), and Baidu Ventures are 5 of 9 investors who have invested in RootPath.

  • Who are RootPath’s competitors?

    Inovio Pharmaceuticals, Noveome Biotherapeutics, Verseau Therapeutics, Carisma Therapeutics, and Allogene Therapeutics are some of the 24 competitors of RootPath.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process